ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Viking Therapeutics Inc

Viking Therapeutics Inc (0VQA)

0.00
0.00
( 0.00% )

Income Statement

Balance Sheet

Cash Flow

Year End December 30 2024 20172018201920202021202220232024
USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000000
Operating Income -19.07M-26.16M-32.69M-42.66M-55.68M-70.36M-100.83M-150.92M
Pre Tax Income -20.58M-22.06M-25.78M-39.5M-54.99M-68.87M-85.9M-109.96M
Net Income -20.58M-22.06M-25.78M-39.5M-54.99M-68.87M-85.9M-109.96M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -0.575-0.308-0.356-0.539-0.703-0.905-0.859-0.987
EBIT -20.58M-25.29M-32.83M-42.77M-55.7M-70.36M-100.83M-150.92M
EBITDA -19.07M-26.16M-32.69M-42.66M-55.68M-70.36M-100.83M-150.92M